Dept. of Pharmaceutical Technology, Institute of Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Hofackerstr. 30, Muttenz 4132, Switzerland.
Adv Drug Deliv Rev. 2019 Mar 1;142:50-61. doi: 10.1016/j.addr.2018.11.003. Epub 2018 Nov 13.
Self-emulsifying and other lipid-based drug delivery systems have drawn considerable interest from pharmaceutical scientists for managing oral delivery of poorly water-soluble compounds. Following administration, self-emulsifying systems exhibit complex aqueous dispersion and digestion in the gastro-intestinal tract. These processes generally result in drug supersaturation, which leads to enhanced absorption or the high drug concentrations may cause precipitation with erratic and variable oral bioavailability. This review briefly outlines drug supersaturation obtained from self-emulsifying and other lipid-based formulations; recent advancements of in vitro lipolysis testing are also discussed. Further, a main focus is mechanisms by which supersaturation is triggered from gastro-intestinal processes, as well as analytical techniques that are promising from a research and development perspective. Comparatively simple approaches are presented together with more sophisticated process analytics to enable direct examination of kinetic changes. The analytical methods together with their sensor probes are discussed in detail to clarify opportunities as well as technical limitations. Some of the more sophisticated methods, including those based on synchrotron radiation, are primarily research oriented despite interesting experimental findings from an industrial viewpoint. The availability of kinetic data further opens the door to mathematical modeling of supersaturation and precipitation versus permeation, which lays the groundwork for better in vitro to in vivo correlations as well as for physiologically-based modeling of lipid-based systems.
自乳化和其他基于脂质的药物传递系统引起了制药科学家的极大兴趣,用于管理水中溶解度差的化合物的口服递送。给药后,自乳化系统在胃肠道中表现出复杂的水相分散和消化。这些过程通常导致药物过饱和,从而增强吸收,或者高药物浓度可能导致沉淀,导致不规则和可变的口服生物利用度。本文简要概述了自乳化和其他基于脂质的制剂中获得的药物过饱和;还讨论了最近体外脂肪分解测试的进展。此外,主要关注的是胃肠道过程引发过饱和的机制,以及从研究和开发角度来看有前途的分析技术。本文提出了一些相对简单的方法,以及更复杂的工艺分析方法,以能够直接检查动力学变化。详细讨论了分析方法及其传感器探头,以阐明机遇和技术限制。尽管从工业角度来看,一些更复杂的方法(包括基于同步辐射的方法)主要是研究性的,但其中一些方法具有有趣的实验结果。动力学数据的可用性进一步为过饱和和沉淀与渗透的数学建模打开了大门,为更好的体外到体内相关性以及基于生理的脂质系统建模奠定了基础。